Brown Advisory’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-8,059
| Closed | -$818K | – | 1411 |
|
|
2025
Q4 | $818K | Sell |
8,059
-6,023
| -43% | -$484K | ﹤0.01% | 903 |
|
|
2025
Q3 | $770K | Buy |
14,082
+3,006
| +27% | +$150K | ﹤0.01% | 907 |
|
|
2025
Q2 | $589K | Buy |
11,076
+5,818
| +111% | +$296K | ﹤0.01% | 956 |
|
|
2025
Q1 | $228K | Sell |
5,258
-40
| -0.8% | -$2.03K | ﹤0.01% | 1227 |
|
|
2024
Q4 | $298K | Sell |
5,298
-1,142
| -18% | -$71.1K | ﹤0.01% | 1159 |
|
|
2024
Q3 | $439K | Sell |
6,440
-1,016
| -14% | -$57.3K | ﹤0.01% | 1016 |
|
|
2024
Q2 | $315K | Sell |
7,456
-692
| -8% | -$38.1K | ﹤0.01% | 1063 |
|
|
2024
Q1 | $563K | Sell |
8,148
-139
| -2% | -$8.79K | ﹤0.01% | 909 |
|
|
2023
Q4 | $613K | Sell |
8,287
-1,489
| -15% | -$97.6K | ﹤0.01% | 878 |
|
|
2023
Q3 | $667K | Sell |
9,776
-322
| -3% | -$27.3K | ﹤0.01% | 837 |
|
|
2023
Q2 | $948K | Sell |
10,098
-535
| -5% | -$41.7K | ﹤0.01% | 762 |
|
|
2023
Q1 | $721K | Sell |
10,633
-160
| -1% | -$10.3K | ﹤0.01% | 833 |
|
|
2022
Q4 | $534K | Sell |
10,793
-655
| -6% | -$26.8K | ﹤0.01% | 895 |
|
|
2022
Q3 | $372K | Sell |
11,448
-1,313
| -10% | -$54.1K | ﹤0.01% | 925 |
|
|
2022
Q2 | $502K | Sell |
12,761
-1,478
| -10% | -$79K | ﹤0.01% | 844 |
|
|
2022
Q1 | $995K | Sell |
14,239
-2,554
| -15% | -$187K | ﹤0.01% | 714 |
|
|
2021
Q4 | $1.31M | Sell |
16,793
-1,538
| -8% | -$136K | ﹤0.01% | 678 |
|
|
2021
Q3 | $1.75M | Sell |
18,331
-16,138
| -47% | -$1.7M | ﹤0.01% | 594 |
|
|
2021
Q2 | $4.29M | Sell |
34,469
-1,002
| -3% | -$120K | 0.01% | 481 |
|
|
2021
Q1 | $4.67M | Buy |
+35,471
| New | +$4.86M | 0.01% | 475 |
|
|
2019
Q2 | – | Sell |
-16,446
| Closed | -$1.43M | – | 1097 |
|
|
2019
Q1 | $1.43M | Sell |
16,446
-6,309
| -28% | -$537K | ﹤0.01% | 722 |
|
|
2018
Q4 | $1.44M | Sell |
22,755
-13,571
| -37% | -$931K | ﹤0.01% | 663 |
|
|
2018
Q3 | $2.87M | Buy |
36,326
+3,787
| +12% | +$247K | 0.01% | 569 |
|
|
2018
Q2 | $1.95M | Buy |
32,539
+25,505
| +363% | +$1.37M | 0.01% | 628 |
|
|
2018
Q1 | $284K | Buy |
7,034
+690
| +11% | +$33.7K | ﹤0.01% | 995 |
|
|
2017
Q4 | $334K | Sell |
6,344
-1,459
| -19% | -$77.9K | ﹤0.01% | 1003 |
|
|
2017
Q3 | $368K | Buy |
+7,803
| New | +$314K | ﹤0.01% | 941 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
Brown Advisory's EXAS Position: Q1 2026 in Review
Brown Advisory sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 8,059 shares — an estimated $818K sold.
Brown Advisory first reported a position in EXAS in Q3 2017 and held it in 27 quarters. The position peaked at $4.67M in Q1 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Brown Advisory reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Brown Advisory sold 8,059 Exact Sciences shares in Q1 2026, an estimated $818K.
- Brown Advisory first reported a position in Exact Sciences in Q3 2017 and held it in 27 quarters.
- Brown Advisory's Exact Sciences position peaked at $4.67M in Q1 2021.
- 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.